# Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

> **NCT04867707** · PHASE2 · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 14 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Zanamivir

## Key facts

- **NCT ID:** NCT04867707
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-14
- **Primary completion:** 2024-10-18
- **Final completion:** 2024-10-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867707, "Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04867707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*